Latest Crucell Stories
Consortia funded through the IMI Ebola+ Programme Supported by the European Commission NEW BRUNSWICK, N.J., Jan.
Company Has Produced More Than 400,000 Vaccine Regimens for Use in Large-Scale Clinical Trials by April 2015 NEW BRUNSWICK, N.J., Jan.
NEW BRUNSWICK, N.J., Oct.
NEW BRUNSWICK, N.J., Sept.
LEIDEN, The Netherlands and SEATTLE, May 3, 2011 /PRNewswire/ -- ProFibrix B.V., a leader in the development of innovative products that help stop bleeding (hemostasis) after surgery, today announced the successful closing of a series B follow-on financing.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.